LAG3 and neoplasm: Interestingly, Huang et al. demonstrated that the dual blockade of antibodies against PD-1/CTLA-4 or triple blockade against PD-1/LAG-3/CTLA-4 resulted in tumor-free survival in 20% of treated mice.